blood brain barrier

Mesenchymal Stem Cells as a Drug Delivery Vehicle for Brain Tumour

Cancer is a disease that can develop anywhere in our body as a result of excessive cell division. The location and cell types influence the etiology, symptoms, severity, and therapeutic approaches. In brain tumours, more than 75% of adults are affected by glioblastoma. The average survival rate is only two years after diagnosis, and the progression of therapeutic strategies is limited and challenging. These are mainly due to the blood-brain barrier (BBB) blockage, which makes intravenous chemotherapeutic compounds difficult to get through, and the relative rarity of this kind of cancer, which makes it difficult to attract pharmaceutical companies.

Read More »

HOW CAN WE HELP YOU? Our specialists are to help you find the best product for your application. We will be happy to help you find the right product for the job.


Contact our Customer Care, Sales & Scientific Assistance


Consult and asked questions about our products & services


Documentation of Technical & Safety Data Sheet, Guides and more..